文献速递糖尿病

载脂蛋白血清水平与2型糖尿病发病:一项前瞻性队列研究

Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study.
PubMed 文献 · Diabetes Care · 2016-12-28

在鹿特丹研究971名基线无糖尿病人群中,中位随访13.5年期间110人发生2型糖尿病。校正年龄、性别、BMI、父母糖尿病史、高血压、饮酒、吸烟、心血管病及降脂药后,HDL-C(每1个自然对数标准差HR 0.74 [95%CI 0.57, 0.97])、载脂蛋白CIII(1.65 [1.42, 1.91])、载脂蛋白E(1.36 [1.18, 1.55])、载脂蛋白CIII与载脂蛋白A1比值(1.72 [1.51, 1.95])、载脂蛋白E与载脂蛋白A1比值(1.28 [1.13, 1.45])及载脂蛋白评分(1.60 [1.39, 1.83])仍有统计学意义;进一步校正甘油三酯后仅载脂蛋白CIII(1.42 [1.03, 1.96])和载脂蛋白CIII与载脂蛋白A1比值(1.56 [1.04, 2.36])仍有统计学意义。作者结论认为载脂蛋白CIII水平及载脂蛋白CIII与载脂蛋白A1比值与2型糖尿病发病相关,独立于已知危险因素且强于HDL-C水平。

要点

  • 载脂蛋白CIII及载脂蛋白CIII与载脂蛋白A1比值与2型糖尿病发病相关,独立于已知危险因素。
  • 校正甘油三酯后仅载脂蛋白CIII和载脂蛋白CIII与载脂蛋白A1比值仍有统计学意义。
  • 载脂蛋白CIII及载脂蛋白CIII与载脂蛋白A1比值的关联强于HDL-C水平。

核心结论

  • 血清载脂蛋白CIII水平及载脂蛋白CIII与载脂蛋白A1比值与2型糖尿病发病相关,独立于已知危险因素且强于HDL-C水平。

研究设计与样本

  • 前瞻性人群队列研究,使用鹿特丹研究971名基线无糖尿病人群的数据,中位随访13.5年。

主要发现

  • 随访期间110人发生2型糖尿病。
  • 校正年龄、性别、BMI、父母糖尿病史、高血压、饮酒、吸烟、现患心血管疾病及降血清脂质药物后,HDL-C每1个自然对数标准差HR 0.74(95%CI 0.57, 0.97),载脂蛋白CIII HR 1.65(95%CI 1.42, 1.91),载脂蛋白E HR 1.36(95%CI 1.18, 1.55),载脂蛋白CIII与载脂蛋白A1比值HR 1.72(95%CI 1.51, 1.95),载脂蛋白E与载脂蛋白A1比值HR 1.28(95%CI 1.13, 1.45),载脂蛋白评分HR 1.60(95%CI 1.39, 1.83),均仍有统计学意义。
  • 进一步校正甘油三酯后,仅载脂蛋白CIII HR 1.42(95%CI 1.03, 1.96)和载脂蛋白CIII与载脂蛋白A1比值HR 1.56(95%CI 1.04, 2.36)仍有统计学意义。

关键数值与推荐

  • HDL-C每1个自然对数标准差HR 0.74(95%CI 0.57, 0.97),校正年龄、性别、BMI、父母糖尿病史、高血压、饮酒、吸烟、现患心血管疾病及降血清脂质药物。
  • 载脂蛋白CIII每1个自然对数标准差HR 1.65(95%CI 1.42, 1.91),校正同上。
  • 载脂蛋白CIII与载脂蛋白A1比值每1个自然对数标准差HR 1.72(95%CI 1.51, 1.95),校正同上。
  • 进一步校正甘油三酯后,载脂蛋白CIII HR 1.42(95%CI 1.03, 1.96),载脂蛋白CIII与载脂蛋白A1比值HR 1.56(95%CI 1.04, 2.36)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to investigate the role of serum levels of various apolipoproteins on the risk for type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We used data from 971 individuals from the prospective population-based Rotterdam Study. We studied the association of HDL cholesterol (HDL-C), apoA1, apoCIII, apoD, and apoE as well as the ratios of apolipoproteins with apoA1 with the risk of T2D. All apolipoproteins, ratios, and HDL-C levels were naturally log-transformed to reach normal distribution. First, their cross-sectional associations with fasting glucose and insulin were investigated by using linear regression. Second, Cox proportional hazard models were used to examine whether apolipoproteins predict the risk for T2D among individuals free of diabetes at baseline. We also studied the apolipoproteins jointly by calculating the apolipoproteinic score from the first step and then performing Cox regression with it. RESULTS: During a median follow-up of 13.5 years, diabetes developed in 110 individuals. After adjustment for age, sex, BMI, parental history of diabetes, hypertension, alcohol use, smoking, prevalent cardiovascular disease, and serum lipid-reducing agents, HDL-C (per 1 SD naturally log-transformed hazard ratio 0.74 [95% CI 0.57, 0.97], apoCIII (1.65 [1.42, 1.91]), apoE (1.36 [1.18, 1.55]), apoCIII-to-apoA1 ratio (1.72 [1.51, 1.95]), apoE-to-apoA1 ratio (1.28 [1.13, 1.45]), and apolipoproteinic score (1.60 [1.39, 1.83]) remained significant. Only apoCIII (1.42 [1.03, 1.96]) and apoCIII-to-apoA1 ratio (1.56 [1.04, 2.36]) survived the adjustment for triglycerides in the last model. CONCLUSIONS: Serum apoCIII levels as well as apoCIII-to-apoA1 ratio are associated with incident T2D. They are associated independent of known risk factors and stronger than HDL-C levels.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Brahimaj A, Ligthart S, Ikram MA, et al. Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2016. PMID: 28031419. doi:10.2337/dc16-1295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。